HansaBioMed Life Sciences Ltd is to research and development of products in the field of Extracellular Vesicles (EVs).
Its mission is to develop and commercialize proprietary platforms, kits, reagents and equipment for EV research in the Life Sciences market.
Our facilities are located in Tallinn (Estonia), in the Tallinn Technology Park (Tehnopol). HansaBioMed Life Sciences offers the widest choice and selection of products dedicated to EV research for Life Science applications available on the global market today. Our scientists have over 10 years of experience in the area of Extracellular Vesicles, high background in molecular and cell biology, in cancer research, and development of diagnostics.
HBM has an active research program; it is a partner in several H2020 projects, and is leading 2 product development and basic science grants.
Starting from 2019 HansaBioMed Life Sciences belongs to Exosomics S.p.A.